|
G3BP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13029996473557E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.92510032756854E-10 |
| Normal-vs-Stage2 |
1.603690E-04 |
| Normal-vs-Stage3 |
4.222000E-04 |
| Normal-vs-Stage4 |
3.006200E-02 |
| Stage1-vs-Stage2 |
4.209600E-01 |
| Stage1-vs-Stage3 |
6.921200E-01 |
| Stage1-vs-Stage4 |
6.985400E-01 |
| Stage2-vs-Stage3 |
7.425200E-01 |
| Stage2-vs-Stage4 |
8.655000E-01 |
| Stage3-vs-Stage4 |
9.269200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4986000218542E-09 |
| Normal-vs-AfricanAmerican |
6.60069999769419E-08 |
| Normal-vs-Asian |
9.249000E-04 |
| Caucasian-vs-AfricanAmerican |
8.494800E-01 |
| Caucasian-vs-Asian |
8.089200E-01 |
| AfricanAmerican-vs-Asian |
8.398400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.83450032942289E-10 |
| Normal-vs-Female |
3.58780000000447E-05 |
| Male-vs-Female |
4.245600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.00359999702471E-08 |
| Normal-vs-Extreme_Weight |
2.00990002419132E-10 |
| Normal-vs-Obese |
3.83489999999931E-06 |
| Normal-vs-Extreme_Obese |
9.9493000000006E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.874200E-01 |
| Normal_Weight-vs-Obese |
1.193570E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.655000E-01 |
| Extreme_Weight-vs-Obese |
6.648000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.563400E-01 |
| Obese-vs-Extreme_Obese |
3.447200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.749600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.14050000344213E-08 |
| Normal-vs-Age(61-80Yrs) |
1.19870002812661E-10 |
| Normal-vs-Age(81-100Yrs) |
3.93680000043695E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.914400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.151000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.210230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.062200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.875610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.317400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.87719983791146E-10 |
| Normal-VS-Type2 PRCC |
1.15379999998666E-08 |
| Normal-VS-KIRP CIMP |
6.885800E-01 |
| Normal-VS-Unclassified PRCC |
3.413000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.182400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.633640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.216200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.530970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.947990E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.133000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.28859997619679E-09 |
| Normal-vs-N1 |
2.896100E-03 |
| Normal-vs-N2 |
4.411200E-01 |
| N0-vs-N1 |
2.922600E-01 |
| N0-vs-N2 |
2.500200E-01 |
| N1-vs-N2 |
7.088400E-01 |
|
|
